Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo

J. A. Martinez-Climent, N. J. Lane, C. M. Rubin, E. Morgan, H. S. Johnstone, R. Mick, S. B. Murphy, J. W. Vardiman, R. A. Larson, M. M. Le Beau, J. D. Rowley

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

We report on the chromosomal pattern of 120 patients with childhood AML de novo. One hundred and fifteen patients (96%) had adequate samples for analysis; 98 (85%) of these showed clonal karyotypic abnormalities. They were classified into cytogenetic subgroups which were closely correlated with FAB subtypes: t(8;21) and M2 (n = 9); t(15;17) and M3 (n = 12); inv(16) and M4Eo (n = 9); t(9;11) and M5a (n = 10); t(11q23) other than t(9;11) and M4-M5 (n = 11); and t(1;22) and M7 (n = 4), In patients with -7/del(7q)(n = 6), leukemia was preceded by MDS in half of the cases, although they had diverse FAB subtypes. Thirty-seven patients had miscellaneous abnormalities. Despite a high CR rate, patients with t(8;21) had a very poor survival: only one child was event-free at 3 years from diagnosis. One third of patients with t(15;17) died during induction. Those eight who achieved CR fared well: only two relapsed, and six were event-free survivors. Patients with inv(16) had a high remission rate and a long survival: five children were in CR 20 to 136 months. Both groups with t(9;11) and t(11q23) had a high remission rate: however, outcome was superior for the t(9;11) group when compared to either the t(11q23) group (EFS at 3 years ± SE, 56+ ± 17% vs. 11 ± 10%, p = 0.07) or to the remaining patients (p = 0.06). Both -7/del(7q) and t(1;22) groups had low CR rates (50%) and poor survival. Cytogenetic analysis identifies clinically distinct subsets of childhood AML and is useful in tailoring treatment for these patients. Favorable cytogenetic groups (t(15;17), inv(16), and t(9;11)) may do well with current therapy protocols, whereas unfavorable groups (t(11q23), t(8;21), -7/del(7q), and t(1;22)) require more effective therapies.

Original languageEnglish (US)
Pages (from-to)95-101
Number of pages7
JournalLeukemia
Volume9
Issue number1
StatePublished - Jan 1 1995

Fingerprint

Acute Myeloid Leukemia
Chromosome Aberrations
Cytogenetics
Survival
Cytogenetic Analysis
Survivors
Leukemia
Therapeutics

Keywords

  • Acute myeloid leukemia
  • Karyotype in childhood leukemia
  • Prognostic significance

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Martinez-Climent, J. A., Lane, N. J., Rubin, C. M., Morgan, E., Johnstone, H. S., Mick, R., ... Rowley, J. D. (1995). Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia, 9(1), 95-101.
Martinez-Climent, J. A. ; Lane, N. J. ; Rubin, C. M. ; Morgan, E. ; Johnstone, H. S. ; Mick, R. ; Murphy, S. B. ; Vardiman, J. W. ; Larson, R. A. ; Le Beau, M. M. ; Rowley, J. D. / Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. In: Leukemia. 1995 ; Vol. 9, No. 1. pp. 95-101.
@article{46b154877a504a80b5c39fae544f8711,
title = "Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo",
abstract = "We report on the chromosomal pattern of 120 patients with childhood AML de novo. One hundred and fifteen patients (96{\%}) had adequate samples for analysis; 98 (85{\%}) of these showed clonal karyotypic abnormalities. They were classified into cytogenetic subgroups which were closely correlated with FAB subtypes: t(8;21) and M2 (n = 9); t(15;17) and M3 (n = 12); inv(16) and M4Eo (n = 9); t(9;11) and M5a (n = 10); t(11q23) other than t(9;11) and M4-M5 (n = 11); and t(1;22) and M7 (n = 4), In patients with -7/del(7q)(n = 6), leukemia was preceded by MDS in half of the cases, although they had diverse FAB subtypes. Thirty-seven patients had miscellaneous abnormalities. Despite a high CR rate, patients with t(8;21) had a very poor survival: only one child was event-free at 3 years from diagnosis. One third of patients with t(15;17) died during induction. Those eight who achieved CR fared well: only two relapsed, and six were event-free survivors. Patients with inv(16) had a high remission rate and a long survival: five children were in CR 20 to 136 months. Both groups with t(9;11) and t(11q23) had a high remission rate: however, outcome was superior for the t(9;11) group when compared to either the t(11q23) group (EFS at 3 years ± SE, 56+ ± 17{\%} vs. 11 ± 10{\%}, p = 0.07) or to the remaining patients (p = 0.06). Both -7/del(7q) and t(1;22) groups had low CR rates (50{\%}) and poor survival. Cytogenetic analysis identifies clinically distinct subsets of childhood AML and is useful in tailoring treatment for these patients. Favorable cytogenetic groups (t(15;17), inv(16), and t(9;11)) may do well with current therapy protocols, whereas unfavorable groups (t(11q23), t(8;21), -7/del(7q), and t(1;22)) require more effective therapies.",
keywords = "Acute myeloid leukemia, Karyotype in childhood leukemia, Prognostic significance",
author = "Martinez-Climent, {J. A.} and Lane, {N. J.} and Rubin, {C. M.} and E. Morgan and Johnstone, {H. S.} and R. Mick and Murphy, {S. B.} and Vardiman, {J. W.} and Larson, {R. A.} and {Le Beau}, {M. M.} and Rowley, {J. D.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "9",
pages = "95--101",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "1",

}

Martinez-Climent, JA, Lane, NJ, Rubin, CM, Morgan, E, Johnstone, HS, Mick, R, Murphy, SB, Vardiman, JW, Larson, RA, Le Beau, MM & Rowley, JD 1995, 'Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo', Leukemia, vol. 9, no. 1, pp. 95-101.

Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. / Martinez-Climent, J. A.; Lane, N. J.; Rubin, C. M.; Morgan, E.; Johnstone, H. S.; Mick, R.; Murphy, S. B.; Vardiman, J. W.; Larson, R. A.; Le Beau, M. M.; Rowley, J. D.

In: Leukemia, Vol. 9, No. 1, 01.01.1995, p. 95-101.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo

AU - Martinez-Climent, J. A.

AU - Lane, N. J.

AU - Rubin, C. M.

AU - Morgan, E.

AU - Johnstone, H. S.

AU - Mick, R.

AU - Murphy, S. B.

AU - Vardiman, J. W.

AU - Larson, R. A.

AU - Le Beau, M. M.

AU - Rowley, J. D.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - We report on the chromosomal pattern of 120 patients with childhood AML de novo. One hundred and fifteen patients (96%) had adequate samples for analysis; 98 (85%) of these showed clonal karyotypic abnormalities. They were classified into cytogenetic subgroups which were closely correlated with FAB subtypes: t(8;21) and M2 (n = 9); t(15;17) and M3 (n = 12); inv(16) and M4Eo (n = 9); t(9;11) and M5a (n = 10); t(11q23) other than t(9;11) and M4-M5 (n = 11); and t(1;22) and M7 (n = 4), In patients with -7/del(7q)(n = 6), leukemia was preceded by MDS in half of the cases, although they had diverse FAB subtypes. Thirty-seven patients had miscellaneous abnormalities. Despite a high CR rate, patients with t(8;21) had a very poor survival: only one child was event-free at 3 years from diagnosis. One third of patients with t(15;17) died during induction. Those eight who achieved CR fared well: only two relapsed, and six were event-free survivors. Patients with inv(16) had a high remission rate and a long survival: five children were in CR 20 to 136 months. Both groups with t(9;11) and t(11q23) had a high remission rate: however, outcome was superior for the t(9;11) group when compared to either the t(11q23) group (EFS at 3 years ± SE, 56+ ± 17% vs. 11 ± 10%, p = 0.07) or to the remaining patients (p = 0.06). Both -7/del(7q) and t(1;22) groups had low CR rates (50%) and poor survival. Cytogenetic analysis identifies clinically distinct subsets of childhood AML and is useful in tailoring treatment for these patients. Favorable cytogenetic groups (t(15;17), inv(16), and t(9;11)) may do well with current therapy protocols, whereas unfavorable groups (t(11q23), t(8;21), -7/del(7q), and t(1;22)) require more effective therapies.

AB - We report on the chromosomal pattern of 120 patients with childhood AML de novo. One hundred and fifteen patients (96%) had adequate samples for analysis; 98 (85%) of these showed clonal karyotypic abnormalities. They were classified into cytogenetic subgroups which were closely correlated with FAB subtypes: t(8;21) and M2 (n = 9); t(15;17) and M3 (n = 12); inv(16) and M4Eo (n = 9); t(9;11) and M5a (n = 10); t(11q23) other than t(9;11) and M4-M5 (n = 11); and t(1;22) and M7 (n = 4), In patients with -7/del(7q)(n = 6), leukemia was preceded by MDS in half of the cases, although they had diverse FAB subtypes. Thirty-seven patients had miscellaneous abnormalities. Despite a high CR rate, patients with t(8;21) had a very poor survival: only one child was event-free at 3 years from diagnosis. One third of patients with t(15;17) died during induction. Those eight who achieved CR fared well: only two relapsed, and six were event-free survivors. Patients with inv(16) had a high remission rate and a long survival: five children were in CR 20 to 136 months. Both groups with t(9;11) and t(11q23) had a high remission rate: however, outcome was superior for the t(9;11) group when compared to either the t(11q23) group (EFS at 3 years ± SE, 56+ ± 17% vs. 11 ± 10%, p = 0.07) or to the remaining patients (p = 0.06). Both -7/del(7q) and t(1;22) groups had low CR rates (50%) and poor survival. Cytogenetic analysis identifies clinically distinct subsets of childhood AML and is useful in tailoring treatment for these patients. Favorable cytogenetic groups (t(15;17), inv(16), and t(9;11)) may do well with current therapy protocols, whereas unfavorable groups (t(11q23), t(8;21), -7/del(7q), and t(1;22)) require more effective therapies.

KW - Acute myeloid leukemia

KW - Karyotype in childhood leukemia

KW - Prognostic significance

UR - http://www.scopus.com/inward/record.url?scp=0028918255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028918255&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 95

EP - 101

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -

Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia. 1995 Jan 1;9(1):95-101.